Within the DC compartment, CD8α+ DCs were required to respond to type I IFN and to prime anti-tumor T cell responses in a pre-clinical melanoma model, as Batf3−/− mice, in which CD8α+ DCs fail to develop, generate very poor spontaneous anti-tumor T cell responses (55). This evidence concerns the gene CD8A and melanoma.